Correlation between the Warburg effect and progression of triple-negative breast cancer

被引:14
|
作者
Liu, Shaojun [1 ]
Li, Yuxuan [1 ]
Yuan, Meng [1 ]
Song, Qing [1 ]
Liu, Min [1 ]
机构
[1] Nanjing Univ Chinese Med, Dept Oncol, Suzhou TCM Hosp, Suzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 12卷
基金
中国国家自然科学基金;
关键词
Warburg effect; glycolysis; metabolic plasticity; triple-negative breast cancer; basal-like breast cancer; METABOLIC PATHWAYS; CELL COMPETITION; DRUG-RESISTANCE; TUMOR DORMANCY; METASTASIS; MECHANISMS; INHIBITION; PROMOTES; CYCLE; ACTIVATION;
D O I
10.3389/fonc.2022.1060495
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Triple-negative breast cancer (TNBC) is ineligible for hormonal therapy and Her-2-targeted therapy due to the negative expression of the estrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2. Although targeted therapy and immunotherapy have been shown to attenuate the aggressiveness of TNBC partially, few patients have benefited from them. The conventional treatment for TNBC remains chemotherapy. Chemoresistance, however, impedes therapeutic progress over time, and chemotherapy toxicity increases the burden of cancer on patients. Therefore, introducing more advantageous TNBC treatment options is a necessity. Metabolic reprogramming centered on glucose metabolism is considered a hallmark of tumors. It is described as tumor cells tend to convert glucose to lactate even under normoxic conditions, a phenomenon known as the Warburg effect. Similar to Darwinian evolution, its emergence is attributed to the selective pressures formed by the hypoxic microenvironment of pre-malignant lesions. Of note, the Warburg effect does not disappear with changes in the microenvironment after the formation of malignant tumor phenotypes. Instead, it forms a constitutive expression mediated by mutations or epigenetic modifications, providing a robust selective survival advantage for primary and metastatic lesions. Expanding evidence has demonstrated that the Warburg effect mediates multiple invasive behaviors in TNBC, including proliferation, metastasis, recurrence, immune escape, and multidrug resistance. Moreover, the Warburg effect-targeted therapy has been testified to be feasible in inhibiting TNBC progression. However, not all TNBCs are sensitive to glycolysis inhibitors because TNBC cells flexibly switch their metabolic patterns to cope with different survival pressures, namely metabolic plasticity. Between the Warburg effect-targeted medicines and the actual curative effect, metabolic plasticity creates a divide that must be continuously researched and bridged.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Overexpression of miR-181a regulates the Warburg effect in triple-negative breast cancer
    Wang, Y.
    Tahiri, H.
    Yang, C.
    Gu, M.
    Ruan, X.
    Hardy, P.
    CLIMACTERIC, 2023, 26 (01) : 64 - 71
  • [2] TRIPLE-NEGATIVE BREAST CANCER: CORRELATION BETWEEN IMAGING AND PATHOLOGICAL FINDINGS
    Zemni, I.
    Haddad, S.
    Adouni, O.
    Ben Hassouna, J.
    Hechiche, M.
    Chargui, R.
    Rahal, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A62 - A62
  • [3] Triple-negative breast cancer: correlation between imaging and pathological findings
    Ko, Eun Sook
    Lee, Byung Hee
    Kim, Hyun-A
    Noh, Woo-Chul
    Kim, Min Suk
    Lee, Sang-Ah
    EUROPEAN RADIOLOGY, 2010, 20 (05) : 1111 - 1117
  • [4] Triple-negative breast cancer: correlation between imaging and pathological findings
    Eun Sook Ko
    Byung Hee Lee
    Hyun-A Kim
    Woo-Chul Noh
    Min Suk Kim
    Sang-Ah Lee
    European Radiology, 2010, 20 : 1111 - 1117
  • [5] MicroRNAs in regulation of triple-negative breast cancer progression
    Dominika Piasecka
    Marcin Braun
    Radzislaw Kordek
    Rafal Sadej
    Hanna Romanska
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 1401 - 1411
  • [6] MicroRNAs in regulation of triple-negative breast cancer progression
    Piasecka, Dominika
    Braun, Marcin
    Kordek, Radzislaw
    Sadej, Rafal
    Romanska, Hanna
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (08) : 1401 - 1411
  • [7] Triple-Negative Breast Cancer: Correlation between MR Imaging and Pathologic Findings
    Uematsu, Takayoshi
    Kasami, Masako
    Yuen, Sachiko
    RADIOLOGY, 2009, 250 (03) : 638 - 647
  • [8] Study on mouse model of triple-negative breast cancer: association between higher parity and triple-negative breast cancer
    Chun Huang
    Xuan Wang
    Baocun Sun
    Man Li
    Xiulan Zhao
    Yanjun Gu
    Yanfen Cui
    Yan Li
    Targeted Oncology, 2015, 10 : 85 - 97
  • [9] Dipyridamole prevents triple-negative breast-cancer progression
    Spano, Daniela
    Marshall, Jean-Claude
    Marino, Natascia
    De Martino, Daniela
    Romano, Alessia
    Scoppettuolo, Maria Nunzia
    Bello, Anna Maria
    Di Dato, Valeria
    Navas, Luigi
    De Vita, Gennaro
    Medaglia, Chiara
    Steeg, Patricia S.
    Zollo, Massimo
    CLINICAL & EXPERIMENTAL METASTASIS, 2013, 30 (01) : 47 - 68
  • [10] Dipyridamole prevents triple-negative breast-cancer progression
    Daniela Spano
    Jean-Claude Marshall
    Natascia Marino
    Daniela De Martino
    Alessia Romano
    Maria Nunzia Scoppettuolo
    Anna Maria Bello
    Valeria Di Dato
    Luigi Navas
    Gennaro De Vita
    Chiara Medaglia
    Patricia S. Steeg
    Massimo Zollo
    Clinical & Experimental Metastasis, 2013, 30 : 47 - 68